Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
30.02
-0.19 (-0.63%)
At close: Aug 15, 2025, 3:45 PM

Amphastar Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
151.61M 144.3M 156.1M 126.35M
Short-Term Investments
70.04M 112.51M 19.66M 10.32M
Long-Term Investments
11M 15.21M 2.41M 3.98M
Other Long-Term Assets
25.99M 25.91M 20.86M 16.66M
Receivables
138.04M 114.94M 88.8M 78.8M
Inventory
153.74M 105.83M 103.58M 92.81M
Other Current Assets
20.65M 2.96M 2.61M 2.56M
Total Current Assets
534.07M 489.6M 378.32M 318.12M
Property-Plant & Equipment
344.63M 315.64M 264.57M 271.49M
Goodwill & Intangibles
590.66M 613.29M 37.3M 38.87M
Total Long-Term Assets
1.04B 1.02B 363.67M 353.41M
Total Assets
1.58B 1.51B 741.99M 671.53M
Account Payables
30.51M 25.44M 20.5M 22.21M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
234K 436K 3.05M 2.2M
Other Current Liabilities
n/a 168.81M 17.55M 23.16M
Total Current Liabilities
173.76M 225.41M 94.86M 103.81M
Long-Term Debt
601.63M 589.2M 72.84M 74.38M
Other Long-Term Liabilities
27.9M 28.78M 14.56M 15.65M
Total Long-Term Liabilities
671.41M 648.08M 118.47M 122.2M
Total Liabilities
845.17M 873.49M 213.33M 226.01M
Total Debt
650.55M 623.64M 102.58M 104.66M
Common Stock
6K 6K 6K 6K
Retained Earnings
568.79M 409.27M 271.72M 180.34M
Comprehensive Income
-9.18M -8.48M -8.62M -6.76M
Shareholders Equity
732.3M 639.42M 528.66M 445.52M
Total Investments
81.03M 127.72M 22.08M 14.3M